Auteur: acs

WMA issues new version of the Declaration of Helsinki |

October 2024 WMA issued a new version of the Declaration of Helsinki. Most striking changes include:

Lees meer

State of play MDR & IVDR implementation |

July 4th the EU Commission organised an information session on MDR/IVDR for international regulators. In case you missed it, please herewith find the presentation: https://health.ec.europa.eu/document/download/93e2d43c-9da8-40b1-b6d8-8f36962c92f9_en?filename=ev_20240704_presentation.pdf

Lees meer

CCMO submission portal changes February 2025 |

https://www.toetsingonline.nl/to/ccmo_web.nsf/CCMO.xsp?page=home New submissions to be done via the new Research Portal. Submissions in review will still be processed through the current system.

Lees meer

October is breast cancer awareness month |

https://www.nationalbreastcancer.org/about-breast-cancer/ Be aware of what you can do to be proactive with your breast health.

Lees meer

A process change for nWMO studies (post-market, non-interventional) per December 2024 |

Note the new Research Portal going live has been postponed until February 2025.

Lees meer

Draft version of new ISO 14155 published for voting |

https://www.iso.org/standard/83968.html A new version of ISO14155 is currently under development, and on 20-JUN-2024 ISO/DIS 14155, replacing ISO14155:2020 when ready, entered the voting phase that terminates on 12-SEP-2024. A couple of interesting elements are in (potentially) impacting riskmanagement and safety for medical device clinical investigations (note the scope seems to have widened no longer excluding IVDs), […]

Lees meer

EU Commission issues updated timeline for EUDAMED |

EU commission issues an updated planning for gradual roll out of the EUDAMED modules, however, the timeline for delivery of the clinical investigations / performance studies module has been set yet. In other words we are still stuck with local approaches when it comes to adverse event reporting to the regulatory bodies involved in clinical […]

Lees meer

MDCG issues guidance on clinical evaluations for orphan devices |

https://health.ec.europa.eu/document/download/daa1fc59-9d2c-4e82-878e-d6fdf12ecd1a_en?filename=mdcg_2024-10_en.pdf By nature ‘orphan devices’ are intended for use in a small number of individuals. This leads to specific challenges for manufacturers and notified bodies on the clinical evidence requirements for the purposes of MDR certification. This MDCG guideline presents guidance on circumstances where it is acceptable to place an orphan device on the market […]

Lees meer

MDCG issues guidance on the investigator’s brochure |

Referencing Annex B of ISO14155:2020, MDCG issues guidance on the investigator’s brochure: https://health.ec.europa.eu/document/download/ee7ee8eb-841a-4085-a8dc-af6d55ebf1bd_en?filename=mdcg_2024-5_en.pdf

Lees meer

MDCG issues guidance on safety reporting in performance studies under IVDR |

https://health.ec.europa.eu/latest-updates/mdcg-2024-4-safety-reporting-performance-studies-vitro-diagnostic-medical-devices-under-regulation-2024-04-15_en

Lees meer